Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Caregivers of Patients With Advanced Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial PEARL evaluating psilocybin-assisted therapy for caregiver distress in the context of advanced cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Caregiver Distress | Phase 2 | Status: NOT_YET_RECRUITING